235 related articles for article (PubMed ID: 20735408)
1. Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to G(s) and G(i).
Chen XP; Yang W; Fan Y; Luo JS; Hong K; Wang Z; Yan JF; Chen X; Lu JX; Benovic JL; Zhou NM
Br J Pharmacol; 2010 Dec; 161(8):1817-34. PubMed ID: 20735408
[TBL] [Abstract][Full Text] [Related]
2. The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain.
Zheng C; Chen L; Chen X; He X; Yang J; Shi Y; Zhou N
PLoS One; 2013; 8(5):e63262. PubMed ID: 23667597
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
[TBL] [Abstract][Full Text] [Related]
4. Differential coupling of beta3A- and beta3B-adrenergic receptors to endogenous and chimeric Galphas and Galphai.
Lenard NR; Prpic V; Adamson AW; Rogers RC; Gettys TW
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E704-15. PubMed ID: 16705062
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.
Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M
Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system.
Zamah AM; Delahunty M; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2002 Aug; 277(34):31249-56. PubMed ID: 12063255
[TBL] [Abstract][Full Text] [Related]
7. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
[TBL] [Abstract][Full Text] [Related]
8. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
Eldeeb K; Leone-Kabler S; Howlett AC
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
[TBL] [Abstract][Full Text] [Related]
9. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
11. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
12. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
13. Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G
Hua T; Li X; Wu L; Iliopoulos-Tsoutsouvas C; Wang Y; Wu M; Shen L; Brust CA; Nikas SP; Song F; Song X; Yuan S; Sun Q; Wu Y; Jiang S; Grim TW; Benchama O; Stahl EL; Zvonok N; Zhao S; Bohn LM; Makriyannis A; Liu ZJ
Cell; 2020 Feb; 180(4):655-665.e18. PubMed ID: 32004463
[TBL] [Abstract][Full Text] [Related]
14. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
Jarrahian A; Watts VJ; Barker EL
J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
[TBL] [Abstract][Full Text] [Related]
15. Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.
Turu G; Várnai P; Gyombolai P; Szidonya L; Offertaler L; Bagdy G; Kunos G; Hunyady L
J Biol Chem; 2009 Jun; 284(25):16914-16921. PubMed ID: 19357084
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal domain of the Gs-coupled EP4 receptor confers agonist-dependent coupling control to Gi but no coupling to Gs in a receptor hybrid with the Gi-coupled EP3 receptor.
Neuschäfer-Rube F; Hänecke K; Blaschke V; Jungermann K; Püschel GP
FEBS Lett; 1997 Jan; 401(2-3):185-90. PubMed ID: 9013884
[TBL] [Abstract][Full Text] [Related]
17. G(i) activator region of alpha(2A)-adrenergic receptors: distinct basic residues mediate G(i) versus G(s) activation.
Wade SM; Lim WK; Lan KL; Chung DA; Nanamori M; Neubig RR
Mol Pharmacol; 1999 Nov; 56(5):1005-13. PubMed ID: 10531407
[TBL] [Abstract][Full Text] [Related]
18. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
Bingham B; Jones PG; Uveges AJ; Kotnis S; Lu P; Smith VA; Sun SC; Resnick L; Chlenov M; He Y; Strassle BW; Cummons TA; Piesla MJ; Harrison JE; Whiteside GT; Kennedy JD
Br J Pharmacol; 2007 Aug; 151(7):1061-70. PubMed ID: 17549048
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector coupling.
Walsh M; Foley JF; Kinsella BT
Biochim Biophys Acta; 2000 Apr; 1496(2-3):164-82. PubMed ID: 10771086
[TBL] [Abstract][Full Text] [Related]
20. Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
Obadiah J; Avidor-Reiss T; Fishburn CS; Carmon S; Bayewitch M; Vogel Z; Fuchs S; Levavi-Sivan B
Cell Mol Neurobiol; 1999 Oct; 19(5):653-64. PubMed ID: 10384262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]